Luoxin Pharmaceutical announced on September 7 that Jiang Ying resigned as board secretary for personal reasons but will continue to serve at the company. At the same time, the board agreed to appoint Li Wentian as the new board secretary, with a term lasting until the end of the sixth board of directors. Li Wentian was born in 1992 and previously held positions at Guosen Securities' investment banking division and Dongxing Securities' investment banking headquarters, as well as serving as director, deputy general manager, and board secretary of Yirui Biotech. In the first half of 2026, Luoxin Pharmaceutical achieved revenue of 1.147 billion yuan and net profit attributable to the parent company of 49.93 million yuan.
Luoxin Pharmaceuticals Group Stock Co LtdBoard secretary Jiang Ying resigns and Li Wentian is appointed; a management change with no clear positive or negative driver.
Guosen Securities Co Ltd
Shenzhen Bioeasy Biotechnology Co. Ltd.
Dongxing Sec Co Ltd